(2,5-Dioxotetrahydro-3-furanyl)acetic acid structure
|
Common Name | (2,5-Dioxotetrahydro-3-furanyl)acetic acid | ||
---|---|---|---|---|
CAS Number | 6318-55-4 | Molecular Weight | 158.109 | |
Density | 1.5±0.1 g/cm3 | Boiling Point | 439.9±18.0 °C at 760 mmHg | |
Molecular Formula | C6H4O5 | Melting Point | 75-78 °C(lit.) | |
MSDS | Chinese USA | Flash Point | 194.6±14.7 °C | |
Symbol |
GHS05 |
Signal Word | Danger |
Name | 2-(2,5-dioxofuran-3-yl)acetic acid |
---|---|
Synonym | More Synonyms |
Density | 1.5±0.1 g/cm3 |
---|---|
Boiling Point | 439.9±18.0 °C at 760 mmHg |
Melting Point | 75-78 °C(lit.) |
Molecular Formula | C6H4O5 |
Molecular Weight | 158.109 |
Flash Point | 194.6±14.7 °C |
Exact Mass | 158.021530 |
PSA | 80.67000 |
LogP | -1.61 |
Vapour Pressure | 0.0±2.3 mmHg at 25°C |
Index of Refraction | 1.506 |
Storage condition | 2-8°C |
Symbol |
GHS05 |
---|---|
Signal Word | Danger |
Hazard Statements | H314 |
Precautionary Statements | P280-P305 + P351 + P338-P310 |
Personal Protective Equipment | Eyeshields;Faceshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges |
Hazard Codes | C |
Risk Phrases | R34 |
Safety Phrases | S26-S36/37/39-S45 |
RIDADR | UN 3261 8/PG 2 |
WGK Germany | 3 |
Packaging Group | III |
Hazard Class | 8 |
HS Code | 2918300090 |
~% (2,5-Dioxotetra... CAS#:6318-55-4 |
Literature: Journal of the Chemical Society, , vol. 61, p. 1009 Journal of the Chemical Society, , vol. 101, p. 1494 Recueil des Travaux Chimiques des Pays-Bas, , vol. 40, p. 383 |
~% (2,5-Dioxotetra... CAS#:6318-55-4 |
Literature: Australian Journal of Chemistry, , vol. 55, # 6-7 SPEC. p. 467 - 474 |
HS Code | 2918300090 |
---|---|
Summary | 2918300090 other carboxylic acids with aldehyde or ketone function but without other oxygen function, their anhydrides, halides, peroxides, peroxyacids and their derivatives。Supervision conditions:None。VAT:17.0%。Tax rebate rate:9.0%。MFN tariff:6.5%。General tariff:30.0% |
Enhanced shRNA delivery and ABCG2 silencing by charge-reversible layered nanocarriers.
Small 11(8) , 952-62, (2015) Polycationic vectors have been used to deliver short hairpin RNAs (shRNAs) to knock-down genes for cancer therapies, but their inefficiency in lysosomal escape and shRNA release causes their low gene ... |
|
Development of biodegradable polymeric implants of RGD-modified PEG-PAMAM-DOX conjugates for long-term intratumoral release.
Drug Deliv. 22 , 389-99, (2015) The sustained release implants can be directly implanted in tumor site by surgery and are promising for cancer treatment.RGD-modified PEGylated polyamidoamine (PAMAM) dendrimer with doxorubicin (DOX) ... |
|
Acid-responsive PEGylated doxorubicin prodrug nanoparticles for neuropilin-1 receptor-mediated targeted drug delivery.
Colloids Surf. B Biointerfaces 136 , 365-74, (2015) Self-assembled prodrug nanoparticles have demonstrated great promise in cancer chemotherapy. In the present study, we developed a new kind of prodrug nanoparticles for targeted drug delivery. PEGylate... |
(2,5-Dioxo-2,5-dihydro-furan-3-yl)-acetic acid |
EINECS 228-663-3 |
cis-acotinic anyhydride |
cis-Aconitic acid anhydride |
3-Furanacetic acid, tetrahydro-2,5-dioxo- |
propene-1,2,3-tricarboxylic acid-1,2-anhydride |
cis-Aconitic anhydride |
cis-Propene-1,2,3-tricarboxylic anhydride |
Aconitic anhydride |
3-Furanacetic acid,2,5-dihydro-2,5-dioxo |
MFCD00005524 |
(2,5-Dioxotetrahydro-3-furanyl)acetic acid |
(Z)-Aconitic anhydride |
carboxymethylmaleic anhydride |